Acetylation controls Notch3 stability and function in T-cell leukemia. - RIIP - Réseau International des Instituts Pasteur Access content directly
Journal Articles Oncogene Year : 2012

Acetylation controls Notch3 stability and function in T-cell leukemia.


Post-translational modifications of Notch3 and their functional role with respect to Notch3 overexpression in T-cell leukemia are still poorly understood. We identify here a specific novel property of Notch3 that is acetylated and deacetylated at lysines 1692 and 1731 by p300 and HDAC1, respectively, a balance impaired by HDAC inhibitors (HDACi) that favor hyperacetylation. By using HDACi and a non-acetylatable Notch3 mutant carrying K/R(1692-1731) mutations in the intracellular domain, we show that Notch3 acetylation primes ubiquitination and proteasomal-mediated degradation of the protein. As a consequence, Notch3 protein expression and its transcriptional activity are decreased both in vitro and in vivo in Notch3 transgenic (tg) mice, thus impairing downstream signaling upon target genes. Consistently, Notch3-induced T-cell proliferation is inhibited by HDACi, whereas it is enhanced by the non-acetylatable Notch3-K/R(1692-1731) mutant. Finally, HDACi-induced Notch3 hyperacetylation prevents in vivo growth of T-cell leukemia/lymphoma in Notch3 tg mice. Together, our findings suggest a novel level of Notch signaling control in which Notch3 acetylation/deacetylation process represents a key regulatory switch, thus representing a suitable druggable target for Notch3-sustained T-cell acute lymphoblastic leukemia therapy.


Embargoed file
Embargoed file
Ne sera jamais visible

Dates and versions

pasteur-00947754 , version 1 (17-02-2014)



R. Palermo, S. Checquolo, A. Giovenco, P. Grazioli, V. Kumar, et al.. Acetylation controls Notch3 stability and function in T-cell leukemia.. Oncogene, 2012, 31 (33), pp.3807-17. ⟨10.1038/onc.2011.533⟩. ⟨pasteur-00947754⟩


20 View
0 Download



Gmail Facebook Twitter LinkedIn More